RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)
$3.24 -0.17 (-4.9853%)
Analysed RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) News Sources
Why Is Recursion Pharmaceuticals (RXRX) Up 8.2% Since Last Earnings Report?
04-09-2026
yahoo.com
2 Beaten-Down Stocks to Avoid Right Now
08-09-2026
fool.com
Why Recursion Pharmaceuticals (RXRX) Dipped More Than Broader Market Today
10-09-2026
yahoo.com
Recursion Pharmaceuticals (RXRX) Stock Still Looks Expensive Following August 5 Results Update
05-08-2026
yahoo.com
Recursion Pharmaceuticals Q2 Earnings Call Highlights
05-08-2026
marketbeat.com
Recursion (RXRX) Q2 2026 Earnings Call Transcript
12-08-2026
fool.com
These Are the Stocks Wall Street Is Betting Against the Most
12-08-2026
yahoo.com
Recursion Pharmaceuticals Highlights AI Platform, Roche Progress and Pipeline Updates
17-08-2026
marketbeat.com
Contineum, Disc Medicine, Recursion Advance Pipelines Ahead of Catalysts, Morgan Stanley Says
17-08-2026
yahoo.com
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci
18-08-2026
yahoo.com
What is the current price of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)?
The current price of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) is $3.24.
RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) since the previous trading day is $-0.17.
RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) since the previous trading day is -4.9853%.
What is the most recent average sentiment score for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)?
The most recent average sentiment score for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)?
The most recent sentiment for RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ) is .
SEC-8K** Filing Available For RECURSION PHARMACEUTICALS-A (RXRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.